Anti-Trypanosoma cruzi Activity of Green Tea (Camellia sinensis) Catechins

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 1, 2004, Pages 69-74

  Paveto, Cristina ^a,c   Güida, María C ^a   Esteva, Mónica I ^b   Martino, Virginia ^a   Coussio, Jorge ^a   Flawiá, Mirtha M ^a   Torres, Héctor N ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b Instituto Nacional de Parasitologia   (Argentina)

^c INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ARGININE KINASE; CATECHIN; CATECHIN GALLATE; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; GALLOCATECHIN; GALLOCATECHIN GALLATE; GREEN TEA EXTRACT; ORGANIC SOLVENT; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BACTERICIDAL ACTIVITY; BLOOD; BLOOD FLOW; COLUMN CHROMATOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DIODE; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG PURIFICATION; DRUG SCREENING; ENERGY METABOLISM; ENZYME INACTIVATION; ENZYME INHIBITION; FRACTIONATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LYSIS; MALE; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTOZOAL INFECTION; TEA; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; VERO CELL;

ANIMALS; ARGININE KINASE; CAMELLIA; CATECHIN; CERCOPITHECUS AETHIOPS; CHAGAS DISEASE; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; INDICATORS AND REAGENTS; MALE; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; VERO CELLS;

EID: 0346731297     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.1.69-74.2004     Document Type: Article

References (33)

1. Alonso, G. D., C. A. Pereira, M. S. Remedi, M. C. Paveto, L. Cochella, M. S. Ivaldi, N. M. Gerez de Burgos, H. N. Torres, and M. M. Flawiá. 2001. Arginine kinase of the flagellate protozoa Trypanosoma cruzi: regulation of its expression and catalytic activity. FEBS Lett. 498:22-25.
2. Asres, K., F. Bucar, E. Knauder, V. Yardley, H. Kendrick, and S. L. Croft. 2001. In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle. Phytother. Res. 15:6113-6117.
3. Bohm, B. A. 1998. Extraction, purification and identification of flavonoids, p. 175-241. In B. Ravindranath (ed.), Introduction to flavonoids. Harwood Academic Publishers, Vancouver, British Columbia, Canada.
4. Brenner, Z. 1962. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. Sao Paulo 4:389-396.
5. Chan, M. M., D. Foge, C. Ho, and H. Huang. 1997. Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem. Pharmacol. 54:1281-1286.
6. Coura, J. R., and S. L. de Castro. 2002. A critical review on Chaga's disease chemotherapy. Mem. Inst. Oswaldo Cruz 97:3-24.
7. Esteva, M., A. M. Ruiz, and A. M. Stoka. 2002. Trypanosoma cruzi: methoprene is a potent agent to sterilize blood infected with trypomastigotes. Exp. Parasitol. 100:248-251.
8. Fraga, C. G., V. S. Martino, G. E. Ferraro, J. D. Coussio, and A. Boveris. 1987. Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem. Pharmacol. 36:717-720.
9. Franke de Cazzulo, B. M., J. Martinez, M. J. North, G. Coombs, and J. J. Cazzulo. 1994. Effects of proteinase inhibitors on the growth and differentiation of Trypanosoma cruzi. FEMS Microbiol. Lett. 124:81-86.
10. Hird, F. J. R. 1986. The importance of arginine in evolution. Comp. Biochem. Physiol. 85B:285-288.
11. Huang, Y., A. Zhang, C. W. Lau, and Z. Y. Chen. 1998. Vasorelaxant effects of purified green tea epigallocatechin derivatives in rat mesenteric artery. Life Sci. 63:275-283.
12. Jankun, J., S. H. Selamn, and R. Swiercz. 1997. Why drinking green tea could prevent cancer. Nature 387:561.
13. Liao, S., and R. A. Hiipakka. 1995. Selective inhibition of steroid 5α-reductase isozymes by tea epicathechin-3-gallate and epigallocatechin-3-gallate. Biochem. Biophys. Res. Commun. 214:833-838.
14. Lira, R., M. L. Contreras, M. R. Santa Rita, and J. A. Urbina. 2001. Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole. J. Antimicrob. Chemother. 47:537-546.
15. Miketoa, P., K. Schram, J. L. Whitney, E. H. Kerns, B. N. Valcic, B. N. Timmermann, and K. J. Volk. 1998. Mass spectrometry of selected component of biological interest in green tea extracts. J. Nat. Prod. 61:461-467.
16. Morré, D. J., A. Bridge, L. Wu, and D. M. Morré. 2000. Preferential inhition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cell in culture. Biochem. Pharmacol. 60:937-974.
17. Pereira, C., G. Alonso, C. Paveto, A. Iribarren, L. Cabanas, H. Torres, and M. Flawiá. 2000. Trypanosoma cruzi arginine kinase characterization and cloning: a novel energetic pathway in protozoan parasites. J. Biol. Chem. 275:1495-1501.
18. Pereira, C. A., G. D. Alonso, M. S. Ivaldi, A. Silber, M. J. M. Alves, L. A. Bouvier, M. M. Flawiá, and H. N. Torres. 2002. Arginine metabolism in Trypanosoma cruzi is coupled to parasite stage and replication. FEBS Lett. 526:111-114.
19. Schmunis, G. A. 1999. Riesgo de la enfermedad de Chagas a través de las transfusiones en América. Medicina (Buenos Aires) 59:125-134.
20. Sepúlveda-Boza, S., and B. K. Cassels. 1996. Plant metabolites active against Trypanosoma cruzi. Planta Med. 62:98-105.
21. Thomas, S. M., and D. G. McPhee. 1984. Crystal violet: a direct acting frame shift mutagen whose mutagenicity is enhanced by mammalian metabolism. Mutat. Res. 140:165-167.
22. Tropical Disease Research. 2000. Central American initiative for elimination of Chagas disease. Progress in vector control and blood bank control. TDR News 63:12.
23. Urbina, J. A. 1999. Chemotherapy of Chagas' disease: the how and the why. J. Mol. Med. 77:332-338.
24. Vijaya, K., S. Ananthan, and R. Nalini. 1995. Antibacterial effect of theaflavin, polyphenon 60 (Camellia sinensis) and Euphorbia hita on Shigella spp.-a cell culture study. J. Ethnopharmacol. 49:115-118.
25. Viotti, R., C. Vigliano, H. Armenti, and E. Segura. 1994. Treatment of chronic Chagas disease with benznidazole: clinical and serological evolution of patients with long-term follow-up. Am. Heart J. 127:151-162.
26. Wang, X., and W. Tian. 2001. Green tea epigallocatechigallate: a natural inhibitor of fatty-acid synthase. Biochem. Biophys. Res. Commun. 288:1200-1206.
27. Weisburger, J. H. 1999. Tea and health: the underlying mechanisms. Proc. Soc. Exp. Biol. Med. 220:271-275.
28. World Health Organization. 1997. Chagas disease. Thirteenth programme report, UNDP/TDR. World Health Organization, Geneva, Switzerland.
29. Yamamoto, T. 1997. Chemistry and application of green tea. CRC Press, Inc., Boca Raton, Fla.
30. Yang, B., K. Arai, and F. Kusu. 2000. Determination of catechins in human urine subsequent to tea ingestion by high-performance liquid chromatography with electrochemical detection. Anal. Biochem. 283:77-82.
31. Yang, T. T., and M. W. Koo. 2000. Chinese green tea lowers cholesterol level through an increase fecal lipid excretion. Life Sci. 66:411-423.
32. Zeeb, D. J., B. C. Nelson, K. Albert, and J. J. Dalluge. 2000. Separation and identification of twelve catechins in tea using liquid chromatography/atmospheric pressure chemical ionization-mass spectrometry. Anal. Chem. 72:5020-5026.
33. Zhu, M., Y. Chen, and R. C. Li. 2000. Oral absortion and bioavailability of tea catechins. Planta Med. 66:444-447.